Anti-Hu CD243 PE

*Kelley DJ, Pavelic ZP, Gapany M, Stambrook P, Pavelic L, Gapany S, Gluckman JL: Detection of P-glycoprotein in squamous cell carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg. 1993 Apr;119 (4) :411-4., URL: http://www.ncbi.nlm.nih.gov/pubmed/8096141 , *Collnot EM, Baldes C, Schaefer UF, Edgar KJ, Wempe MF, Lehr CM: Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharm. 2010 Jun 7;7 (3) :642-51., URL: http://www.ncbi.nlm.nih.gov/pubmed/20205474 , *Goda K, Fenyvesi F, Bacsó Z, Nagy H, Márián T, Megyeri A, Krasznai Z, Juhász I, Vecsernyés M, Szabó G Jr: Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody. J Pharmacol Exp Ther. 2007 Jan;320 (1) :81-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/17050779 , *Mechetner EB, Roninson IB: Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci U S A. 1992 Jul 1;89 (13) :5824-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/1352877 , *Chaudhary PM, Mechetner EB, Roninson IB: Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood. 1992 Dec 1;80 (11) :2735-9., URL: http://www.ncbi.nlm.nih.gov/pubmed/?term=chaudhary+pm+mechetner+eb